公司资料
Biodesix 股价、新闻与催化剂
- 股票代码:
- BDSX
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
23.25 USD (-3.13%)
收盘价
最后更新: 2026年8月17日
160M USD
市值
股价为何变动
As of Aug 17, 2026, BDSX closed down 3.13% at $23.25. No new same-company headline was identified in the current news window.
公司概览
Lung-Disease Diagnostics
Biodesix develops and commercializes diagnostic solutions intended to improve clinical decision-making, with a particular focus on lung disease and oncology. Its tests combine multiple analytical technologies with clinical evidence and laboratory operations.
Diagnostic Testing
The company provides blood-based and other diagnostic tests that help physicians characterize disease, guide treatment and monitor patients. Its commercial laboratory infrastructure supports ordering, sample processing and reporting for routine clinical use.
Development Services
Biodesix also works with biopharmaceutical, life-sciences and research organizations to develop diagnostics, tools and therapeutics. These services combine scientific, technological and operational capabilities and can support biomarker strategy from research through clinical development.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。